Novel Lipid Nanoparticles Entirely Built on a POZ Platform

9:00 am - Tuesday 7th April 2026

  • Overcoming the PEG dilemma with PEOZ-lipids in lipid nanoparticle formulations
  • Design and synthesis of novel ionizable Poly (2-Oxazoline) (POZ) lipids to replace current ionizable lipids
  • Developing POZ-based lipid nanoparticles for the delivery of a multitude of oligonucleotide payloads

Speakers:

Chief Development Officer
Serina Therapeutics